Recent actions by President Donald Trump's administration, including staff cuts at the Food and Drug Administration, have ...

Q3 2025 Management View CEO Kim Kelderman highlighted 6% organic revenue growth amidst a challenging macro environment. Key drivers included strength in core reagents, automated analytical solutions, ...

Discover IRADIMED's record Q1 2025 earnings, growth in IV pump sales, and FDA updates for the 3870 MR IV pump.